Retrons adapted from E. coli enable genome editing in 15 diverse bacterial species, expanding recombineering tools across major microbial phyla.

Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

Aging research has entered a transformative era with the advent of genome editing technologies, particularly CRISPR-Cas9, which enable precise and efficient ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

Colossal Biosciences’ bluebuck de-extinction project could also help the world’s dozens of currently endangered antelope ...

Dallas-based Colossal Biosciences has moved into the gene-editing phase of its project to revive the bluebuck, a South African antelope extinct since around 1800. Using DNA from a preserved specimen ...

Profluent and Lilly teamed up on AI‑designed enzymes in a deal worth up to $2.25B. Big tech, bigger gene edits.

A new method called Tracking-seq can spot off-target effects across multiple CRISPR genome editing tools in just 1–2 weeks. By tracing replication protein A bound to single-stranded DNA, it reveals ...

Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox– Additional presentations ...

Plus: BSN acquires Sports Endeavors to expand portfolio and Hong Kong-based Pudu Robotics establishes U.S. headquarters in Richardson.

Venter led the private effort to sequence the human genome and created the first synthetic bacterial cell while launching ...